TrialFrontiers in immunology2025

Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a prospective cohort study.

Wen Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.